pharmaceuticals
publication date
Revenue Cycle
Making the Case for 340B Reforms
Ryan Long, the co-author of a recent USC Schaeffer Center white paper on the 340B Drug Pricing Program, argues that...
CMO
Trump Claims 'No Downside' to Avoiding Tylenol During Pregnancy. He's Wrong.
Trump's advice has no clear basis in research and contradicts long-standing science and medical guidance.
CMO
Why Are More Older People Dying After Falls?
In 2023, the most recent year of data from the CDC, more than 41,000 Americans over 65 died from falls.
Revenue Cycle
AHA Asks DOJ, FTC to Probe Drugmakers for Anticompetitive 340B Tactics
The American Hospital Association says that the timing of drug companies' proposed 340B rebate model suggests a collective effort to...
Payer
As Insurers Struggle with GLP-1 Drug Costs, Some Seek to Wean Patients Off
Research suggests GLP-1s must be used indefinitely to maintain weight loss and related health benefits.
Innovation
AI and Medication Adherence: Training Tech on Bad Behaviors
Pharmacies and providers are turning to AI to better understand why their patients aren?t following doctors? orders on their prescriptions.
Revenue Cycle
Could This HRSA Pilot Program Signal Future Changes to the 340B Program?
HRSA is piloting a 340B rebate model similar to one that it just fought against. As the agency dips its...
Revenue Cycle
Infographic: Are Drug Companies or Hospitals More Likely to Violate 340B Rules?
In a recent analysis of HRSA data, the American Hospital Association has turned the tables on drug companies and accused...
Technology
Can New DEA Leadership Resolve the Telemedicine Prescription Debate?
A widely panned proposal to regulate virtual prescriptions for controlled drugs isn?t going anywhere. It?s time to bring federal regulators...
Pharma
FDA Layoffs Could Compromise Safety of Medications Made at Foreign Factories, Inspectors Say
Beyond staff cuts, the departures of investigators in recent months have left less experienced people tasked with rooting out dangerous...
Payer
Trump Won't Force Medicaid to Cover GLP-1s for Obesity. A Few States Are Doing It Anyway.
The pricey medications remain out of reach for millions of patients across the country who could benefit from them.
Payer
Mostly False: Trump Exaggerates Speed and Certainty of Prescription Drug Price Reductions
Under a new executive order, prescription drug prices will be reduced 'almost immediately.' ? President Donald Trump, in a May...